home / stock / adma / adma news

ADMA News and Press, ADMA Biologics Inc From 10/21/19

Stock Information
Company Name: ADMA Biologics Inc
Stock Symbol: ADMA
Market: NASDAQ
Website: admabiologics.com
Menu
ADMA ADMA Quote ADMA Short ADMA News ADMA Articles ADMA Message Board
Get ADMA Alerts

News, Short Squeeze, Breakout and More Instantly...
ADMA - ADMA Biologics Announces First Commercial Sales of ASCENIV(TM)

RAMSEY, N.J. and BOCA RATON, Fla., Oct. 21, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), a commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for ...
ADMA - ADMA Biologics Announces Publication of an Article Describing the Manufacturing Process Optimization for its Commercial Products BIVIGAM® and ASCENIV(TM) in the Peer Reviewed Journal Immunotherapy

RAMSEY, N.J. and BOCA RATON, Fla., Oct. 17, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), a commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for ...

ADMA - ADMA Biologics Announces Data Presented at IDWeek 2019

RAMSEY, N.J. and BOCA RATON, Fla., Oct. 07, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical and specialty immunoglobulin company that manufactures, markets and develops s...

ADMA - ADMA Biologics Announces Poster Presentation at IDWeek 2019

RAMSEY, N.J. and BOCA RATON, Fla., Oct. 03, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical and specialty immunoglobulin company that manufactures, markets and develops s...
ADMA - ADMA Biologics to Present at 2019 Cantor Global Healthcare Conference

RAMSEY, N.J. and BOCA RATON, Fla., Sept. 23, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical and specialty immunoglobulin company that manufactures, markets and develops ...

ADMA - ADMA: Ready To Capitalize On The IVIG Shortage

Over the past few months, ADMA Biologics ( ADMA ) has been able to record several key accomplishments and milestones. During the second quarter, the company received FDA approval for both BIVIGAM and ASCENIV. In addition, the company now has product licenses for Nabi-HB and BIVIGAM. What is mo...

ADMA - ADMA Biologics relaunches BIVIGAM; shares up 3% premarket

ADMA Biologics (NASDAQ: ADMA ) announces the commercial relaunch and its first commercial sales of BIVIGAM. More news on: ADMA Biologics, Inc., Healthcare stocks news, Stocks on the move, Read more ...

ADMA - ADMA Biologics Announces Commercial Relaunch and its First Commercial Sales of BIVIGAM®

RAMSEY, N.J. and BOCA RATON, Fla., Aug. 22, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical and specialty immunoglobulin company that manufactures and markets three appro...

ADMA - ADMA Biologics EPS beats by $0.04, beats on revenue

ADMA Biologics (NASDAQ: ADMA ): Q2 GAAP EPS of -$0.25 beats by $0.04 . More news on: ADMA Biologics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

ADMA - ADMA Biologics Reports Second Quarter and First Half 2019 Financial Results

RAMSEY, N.J. and BOCA RATON, Fla., Aug. 08, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical and specialty immunoglobulin company that manufactures, markets and develops s...
Previous 10 Next 10